407 related articles for article (PubMed ID: 36419880)
1. Impact of intestinal dysbiosis on breast cancer metastasis and progression.
Zhang J; Xie Q; Huo X; Liu Z; Da M; Yuan M; Zhao Y; Shen G
Front Oncol; 2022; 12():1037831. PubMed ID: 36419880
[TBL] [Abstract][Full Text] [Related]
2. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
3. Gut colonization with an obesity-associated enteropathogenic microbe modulates the premetastatic niches to promote breast cancer lung and liver metastasis.
Parida S; Siddharth S; Gatla HR; Wu S; Wang G; Gabrielson K; Sears CL; Ladle BH; Sharma D
Front Immunol; 2023; 14():1194931. PubMed ID: 37503343
[TBL] [Abstract][Full Text] [Related]
4. The Gut Microbiota: A Potential Gateway to Improved Health Outcomes in Breast Cancer Treatment and Survivorship.
Sampsell K; Hao D; Reimer RA
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287442
[TBL] [Abstract][Full Text] [Related]
5. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
[TBL] [Abstract][Full Text] [Related]
6. Dysbiosis is one of the risk factor for stroke and cognitive impairment and potential target for treatment.
Koszewicz M; Jaroch J; Brzecka A; Ejma M; Budrewicz S; Mikhaleva LM; Muresanu C; Schield P; Somasundaram SG; Kirkland CE; Avila-Rodriguez M; Aliev G
Pharmacol Res; 2021 Feb; 164():105277. PubMed ID: 33166735
[TBL] [Abstract][Full Text] [Related]
7. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
8. A review on Impact of dietary interventions, drugs, and traditional herbal supplements on the gut microbiome.
Karim MR; Iqbal S; Mohammad S; Lee JH; Jung D; Mathiyalagan R; Yang DC; Yang DU; Kang SC
Microbiol Res; 2023 Jun; 271():127346. PubMed ID: 36921399
[TBL] [Abstract][Full Text] [Related]
9. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer.
Ahmad Kendong SM; Raja Ali RA; Nawawi KNM; Ahmad HF; Mokhtar NM
Front Cell Infect Microbiol; 2021; 11():744606. PubMed ID: 34966694
[TBL] [Abstract][Full Text] [Related]
10. [Significance and effects of prenatal and postnatal microbiome in the period of early individual development and options for interventional treatment].
Fülöp V; Demeter J; Cseh Á
Orv Hetil; 2021 May; 162(19):731-740. PubMed ID: 33965906
[TBL] [Abstract][Full Text] [Related]
11. The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses.
Jaye K; Li CG; Bhuyan DJ
Crit Rev Oncol Hematol; 2021 Sep; 165():103429. PubMed ID: 34293459
[TBL] [Abstract][Full Text] [Related]
12. Potential role of gut microbiota in prostate cancer: immunity, metabolites, pathways of action?
Zha C; Peng Z; Huang K; Tang K; Wang Q; Zhu L; Che B; Li W; Xu S; Huang T; Yu Y; Zhang W
Front Oncol; 2023; 13():1196217. PubMed ID: 37265797
[TBL] [Abstract][Full Text] [Related]
13. Potential Impacts of Prebiotics and Probiotics on Cancer Prevention.
Samanta S
Anticancer Agents Med Chem; 2022; 22(4):605-628. PubMed ID: 33305713
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic role of the gut microbiota in gastrointestinal diseases.
Nagao-Kitamoto H; Kitamoto S; Kuffa P; Kamada N
Intest Res; 2016 Apr; 14(2):127-38. PubMed ID: 27175113
[TBL] [Abstract][Full Text] [Related]
15. Gut Dysbiosis Contributes to the Imbalance of Treg and Th17 Cells in Graves' Disease Patients by Propionic Acid.
Su X; Yin X; Liu Y; Yan X; Zhang S; Wang X; Lin Z; Zhou X; Gao J; Wang Z; Zhang Q
J Clin Endocrinol Metab; 2020 Nov; 105(11):. PubMed ID: 32785703
[TBL] [Abstract][Full Text] [Related]
16. The possible mechanisms of the human microbiome in allergic diseases.
Ipci K; Altıntoprak N; Muluk NB; Senturk M; Cingi C
Eur Arch Otorhinolaryngol; 2017 Feb; 274(2):617-626. PubMed ID: 27115907
[TBL] [Abstract][Full Text] [Related]
17. Fecal metabonomics combined with 16S rRNA gene sequencing to analyze the changes of gut microbiota in rats with kidney-yang deficiency syndrome and the intervention effect of You-gui pill.
Chen R; Wang J; Zhan R; Zhang L; Wang X
J Ethnopharmacol; 2019 Nov; 244():112139. PubMed ID: 31401318
[TBL] [Abstract][Full Text] [Related]
18. Association of breast and gut microbiota dysbiosis and the risk of breast cancer: a case-control clinical study.
Plaza-Díaz J; Álvarez-Mercado AI; Ruiz-Marín CM; Reina-Pérez I; Pérez-Alonso AJ; Sánchez-Andujar MB; Torné P; Gallart-Aragón T; Sánchez-Barrón MT; Reyes Lartategui S; García F; Chueca N; Moreno-Delgado A; Torres-Martínez K; Sáez-Lara MJ; Robles-Sánchez C; Fernández MF; Fontana L
BMC Cancer; 2019 May; 19(1):495. PubMed ID: 31126257
[TBL] [Abstract][Full Text] [Related]
19. The crosstalk between the gut microbiota and tumor immunity: Implications for cancer progression and treatment outcomes.
Wang M; Zhang L; Chang W; Zhang Y
Front Immunol; 2022; 13():1096551. PubMed ID: 36726985
[TBL] [Abstract][Full Text] [Related]
20. Role of Gut Microbiota Dysbiosis in Breast Cancer and Novel Approaches in Prevention, Diagnosis, and Treatment.
Ruo SW; Alkayyali T; Win M; Tara A; Joseph C; Kannan A; Srivastava K; Ochuba O; Sandhu JK; Went TR; Sultan W; Kantamaneni K; Poudel S
Cureus; 2021 Aug; 13(8):e17472. PubMed ID: 34513524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
